Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - thiamine hydrochloride, quantity: 10 mg/ml; riboflavine sodium phosphate, quantity: 2.5 mg/ml; pyridoxine hydrochloride, quantity: 5 mg/ml; dexpanthenol, quantity: 2.5 mg/ml; nicotinamide, quantity: 25 mg/ml; cyanocobalamin, quantity: 0.5 mg/ml - injection, solution - excipient ingredients: water for injections - b vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of b vitamins may be insufficient in; alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. commonly, several b vitamin deficiencies may occur similtaneously. specific indications include: 1. rapid saturation of the b group vitamins. 2. when oral administration is not feasible or appropriate. 3. for alcoholic, debilitated and elderly patients when their diet is inadequate. 4. recovery from beriberi and wernicke's syndrome as a result of vitamin b1 deficiency. please note that b-dose 2ml injection does not contain sufficient thiamine for acute treatment of wernicke's syndrome. 5. pellagra as a result of vitamin b3 deficiency. patients with pellagra may have a concurrent deficiency of b1, b2, b6 and b12. 6. peripheral neuritis caused by various b group deficiencies. 7.

Ireland - English - HPRA (Health Products Regulatory Authority)

bayer plc - ascorbic acid thiamine hydrochloride riboflavin nicotinamide calcium pantothenate pyridoxine hydrochloride cyanocobalamin folic acid biotin calcium carbonate magnesium carbonate magnesium oxide zinc citrate trihydrate - tablets chewable - %v/v

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

winwa medical sdn. bhd. - thiamine mononitrate; vitamin b2 (riboflavin); nicotinamide; calcium d-pantothenate; pyridoxine hydrochloride; cyanocobalamin; ascorbic acid (vitamin c); sodium ascorbate; zinc citrate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

mega lifesciences sdn. bhd. - thiamine hydrochloride; riboflavin; nicotinamide; calcium pantothenate; pyridoxine hydrochloride; cyanocobalamin; ascorbic acid (vitamin c); calcium ascorbate dihydrate; choline bitartrate; inositol; biotin; lecithin; folic acid; magnesium phosphate -

United Kingdom - English - VMD (Veterinary Medicines Directorate)

norbrook laboratories limited - alpha tocopheryl acetate, cholecalciferol, cyanocobalamin, dexpanthenol, nicotinamide, pyridoxine hydrochloride, retinol palmitate, riboflavine sodium phosphate, thiamine hydrochloride -

United Kingdom - English - VMD (Veterinary Medicines Directorate)

norbrook laboratories limited - alpha tocopheryl acetate, cholecalciferol, cyanocobalamin, dexpanthenol, nicotinamide, pyridoxine hydrochloride, retinol palmitate, riboflavine sodium phosphate, thiamine hydrochloride -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

duopharma manufacturing (bangi) sdn bhd - thiamine hydrochloride/vit b1; cyanocobalamin; nicotinamide; pyridoxine hcl/vitamin b6; riboflavine -

Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - thiamine hydrochloride, quantity: 100 mg/ml; riboflavine sodium phosphate, quantity: 2 mg/ml; nicotinamide, quantity: 20 mg/ml; dexpanthenol, quantity: 20 mg/ml; pyridoxine hydrochloride, quantity: 40 mg/ml; cyanocobalamin, quantity: 0.4 mg/ml - injection, solution - excipient ingredients: disodium edetate; benzyl alcohol; water for injections - b vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of b vitamins may be insufficient in; alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. specific indications include: 1. rapid saturation of the b group vitamins. 2. when oral administration is not feasible or appropriate. 3. for alcoholic, debilitated and elderly patients when their diet is inadequate. 4. beriberi and wernicke's syndrome as a result of vitamin b1 deficiency. 5. pellagra as a result of vitamin b3 deficiency. patients with pellagra may have a concurrent deficiency of b1, b2, b6 and b12. 6. peripheral neuritis caused by various b group deficiencies. 7. carpal tunnel syndrome. 8. pernicious anaemia as a result of in situ b12 deficiency. general indications include: 1. angular stomatitis and glossitis have been shown in some instances to respond to t

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

cambert(m) sdn bhd - tagetes erecta (marigold) extract; retinyl acetate; cholecalciferol; dl-alpha tocopheryl acetate; biotin; folic acid; nicotinamide; pyridoxine hydrochloride; thiamine hydrochloride; cyanocobalamin; riboflavin; ascorbic acid (vitamin c); vitamin k2; d-calcium pantothenate; lysine hci; inulin; taurine -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

cameron bioscience (m) sdn bhd - retinyl palmitate; thiamine nitrate; vitamin b2 (riboflavin); nicotinamide; calcium pantothenate; pyridoxine hydrochloride; cyanocobalamin; biotin; folic acid -